...
【24h】

Hepatitis C virus entry: Role of host and viral factors

机译:丙型肝炎病毒进入:宿主和病毒因素的作用

获取原文
获取原文并翻译 | 示例
           

摘要

Hepatitis C virus (HCV) has been considered to be a significant risk factor in developing liver associated diseases including hepatocellular carcinoma all over the world. HCV is an enveloped positive strand virus comprising a complex between genomic RNA and viral envelope glycoproteins (El and E2), which are anchored within host derived double-layered lipid membrane surrounding the nucleocapsid composed of several copies of core protein. HCV cell entry is the first step in infection and viral replication into host cells mainly hepatocytes. HCV cell entry is a complex process involving both the viral (envelope glycoproteins E1/E2) and host factors (cellular receptors and associated factors i.e. CD81, SR-BI, LDL-R, CLDN1, Occludin, DC-SIGN, L-SIGN andGlycosaminoglycans). Besides these the expression of certain other conditions such as polarization and EWI-2 expression inhibits the viral cell entry. Exploring the mechanism of HCV entry will help to better understand the viral life cycle and possibletherapeutic targets against HCV infection including viral and host factors involved in this process. New strategies such as RNAi represents a new option for targeting the host or viral factors for prevention and therapeutic against HCV infection. In thecurrent review we try to summarize the current knowledge about mechanism and interaction of cellular and viral factors involved in HCV cell entry and its implication as therapeutic target to inhibit HCV infection.
机译:丙型肝炎病毒(HCV)被认为是在全世界范围内发展包括肝细胞癌在内的肝脏相关疾病的重要危险因素。 HCV是一种包膜正链病毒,包含基因组RNA和病毒包膜糖蛋白(E1和E2)之间的复合物,该复合物锚定在宿主衍生的双层脂质膜中,该膜围绕着由几份核心蛋白组成的核衣壳。 HCV细胞进入是感染和病毒复制进入宿主细胞(主要是肝细胞)的第一步。 HCV细胞进入是一个复杂的过程,涉及病毒(包膜糖蛋白E1 / E2)和宿主因子(细胞受体及相关因子,即CD81,SR-BI,LDL-R,CLDN1,Occludin,DC-SIGN,L-SIGN和糖胺聚糖) )。除了这些,某些其他条件的表达,例如极化和EWI-2表达,也抑制了病毒细胞的进入。探索HCV进入的机制将有助于更好地了解病毒生命周期以及针对HCV感染的可能治疗靶标,包括此过程中涉及的病毒和宿主因素。 RNAi等新策略代表了针对宿主或病毒因子的新选择,以预防和治疗HCV感染。在当前的综述中,我们试图总结有关参与HCV细胞进入的细胞和病毒因素的机制和相互作用的最新知识,以及其作为抑制HCV感染的治疗靶标的含义。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号